Merck's ($MRK) manufacturing overhaul is forcing job cuts at another Irish plant. A few months after announcing a 20% payroll cut in Brinny, the company is planning to shut down a plant in Rathdrum that employs some 280 people. Report
Undertaking commercialization strategy and planning from early stages of development can ensure that considerable R&D investment results in successful market and patient access. Join HERON, a PAREXEL Company, in a timely webinar that addresses best practice commercialization planning. Register to watch now!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!